Dementia and stroke: The importance of coexisting brain pathologies;Demencia e ictus: La importancia de la enfermedad cerebral coexistente

Revista de Neurologia

Volumn 36, Issue 1, 2003, Pages 61-63

  Merino, José G ^a,c   Hachinski, V ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

Author keywords

Alzheimer's disease; Diagnostic criteria; Mixed dementia; Vascular cognitive deterioration; Vascular dementia; Vascular risk factors

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL FEATURE; COMORBIDITY; DEMENTIA; DIAGNOSTIC PROCEDURE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; HEREDITY; HUMAN; NEUROPATHOLOGY; PATHOGENESIS; RISK FACTOR; STROKE; VASCULAR DISEASE;

EID: 0037227205     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3601.2002467     Document Type: Article

References (28)

1. Scheinberg P. Dementia due to vascular disease: a multifactorial disorder. Stroke 1988; 19: 1291-9.
2. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970; 11: 205-42.
3. del Ser T, Bermejo F, Portera A, Arredondo JM, Bouras C, Constantinidis J. Vascular dementia: a clinicopathological study. J Neurol Sci 1990; 96: 1-17.
4. Erkinjuntti T, Haltia M, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia - a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988; 51: 1037-44.
5. Tatemichi TK, Desmond DW, Paik M, Figueroa M, Gropen TI, Stern Y, et al. Clinical determinants of dementia related to stroke. Ann Neurol 1993; 33: 568-75.
6. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997; 63: 749-53.
7. Tatemichi TK, Desmond DW, Prohovnik I. Strategic infarcts in vascular dementia. A clinical and brain imaging experience. Arzneimittelforschung 1995; 45: 371-85.
8. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke. A population-based study in Rochester, Minnesota (1960-1984). Neurology 1996; 19: 154-9.
9. Hénon H, Pasquier F, Durieu I, Godefroy O, Lucas C, Lebert F, et al. Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997; 28: 2429-36.
10. Barba R, Martínez-Espinosa S, Rodríguez-García E, Pondal M, Vivancos J, del Ser T. Poststroke dementia: clinical features and risk factors. Stroke 2000; 31: 1494-501.
11. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study: Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169-75.
12. Victoroff J, Mack WJ, Lyness SC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995; 152: 1476-84.
13. Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA. Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions. Dementia 1995; 6: 162-8.
14. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markersbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA 1997; 277: 813-7.
15. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, Donald B, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 165-70.
16. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease. CERAD, part XVIII. Neurology 1998; 51: 159-62.
17. Breteler MMB. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging 2000; 21: 153-60.
18. Slooter AJ, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, et al. Apolipoprotein E ε4 and the risk of dementia with stroke. A population-based investigation. JAMA 1997; 277: 818-21.
19. Laskowitz DT, Horsburg K, Roses AD. Apolipoprotein E and the CNS response to injury. J Cereb Blood Flow Metab 1998; 18: 465-71.
20. Sparks DL, Scheff SW, Liu H, Landers T, Danner F, Coyne CM, et al. Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients. J Neurol Sci 1996; 138: 97-104.
21. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349: 151-4.
22. Notkola IL, Sulkava R, Pekkanen J, Erkinjunti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, Apolipoprotein ε4 allele, and Alzheimer's disease. Neuroepidemiology 1998; 17: 14-20.
23. Slooter AJ, Cruts M, Ott A, Bots ML, Witterman JC, Hofman A, et al. The effect of APOE on dementia is not through atherosclerosis: the Rotterdam Study. Neurology 1999; 53: 1593-5.
24. Amouyel P, Richard F, Berr C, David-Fromentin I, Helbecque N. The renin angiotensin system and Alzheimer's disease. Ann N Y Acad Sci 2000; 903: 437-41.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4 ed. Washington DC: American Psychiatric Association; 1994.
27. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143-53.
28. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Lilienfeld S, Damaraju CV. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359: 1283-90.